How do atopic dermatitis trialists perceive the Harmonising Outcomes Measurement in Eczema (HOME) core outcome set? A survey study from the HOME initiative
The Harmonising Outcomes Measurement in Eczema (HOME) initiative developed a core outcome set (COS) for atopic dermatitis (AD), but uptake in trials is still limited. An online survey was sent out to corresponding authors of AD interventional randomized clinical trials to assess their awareness of the HOME COS, evaluate barriers to uptake and identify facilitators to enhance implementation. Survey respondents emphasized increasing awareness of the COS in the research community, reducing the burden associated with using the COS and ensuring applicability to diverse populations.
Authors
- Hywel C Williams (ORCID: https://orcid.org/0000-0002-5646-3093)
- Kim S Thomas (ORCID: https://orcid.org/0000-0001-7785-7465)
- Louise A. A. Gerbens (ORCID: https://orcid.org/0000-0002-5244-5058)
- Yael A. Leshem
- Jochen Schmitt (ORCID: https://orcid.org/0000-0003-0264-0960)
- Phyllis I. Spuls (ORCID: https://orcid.org/0000-0002-6035-2863)
- Christian Apfelbacher (ORCID: https://orcid.org/0000-0003-3805-8219)
- M. E. Jacobson (ORCID: https://orcid.org/0000-0003-4105-1958)
- Yuval Gilad (ORCID: https://orcid.org/0000-0001-6465-3789)
- Eric L. Simpson (ORCID: https://orcid.org/0000-0002-8793-7087)
- Norito Katoh
Institutions
- University of Nottingham (GB)
- Tel Aviv University (IL)
- Oregon Health & Science University (US)
- Kyoto Prefectural University (JP)
- Nanyang Technological University (SG)
- Sheba Medical Center (IL)
- Rabin Medical Center (IL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Kyoto Prefectural University of Medicine (JP)
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- University Hospital Carl Gustav Carus (DE)
- Technische Universität Dresden (DE)
- University of Amsterdam (NL)
- Otto-von-Guericke-Universität Magdeburg (DE)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1093/ced/llaf191
- Citations
- 1
- Primary Topic
- Delphi Technique in Research
- Type
- article
- Field-Weighted Citation Impact
- 4.20
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Regeneron Pharmaceuticals
- Valeant Pharmaceuticals International
- National Jewish Health
- Dermira
- Incyte
- European Commission
- Nanyang Technological University
- Universiteit van Amsterdam
- Tel Aviv University
- Otsuka Pharmaceutical
- Faculty of Health and Medical Sciences, University of Western Australia
- Galderma
- Sun Pharma
- Gemeinsame Bundesausschuss
- LEO Pharma
- Genentech
- Eli Lilly Japan
- Lee Kong Chian School of Medicine, Nanyang Technological University
- Otto von Guericke University Magdeburg